Bruges Metropolitan Area
Professional Experience: - Extensive mass spectrometry expertise, concerning method development and validation in the field of small molecules and residue analysis (thyreostats, steroids, veterinary drugs, bile acids, pharmaceuticals, perfluorinated compounds, DNA adducts etc.) - Active involvement in different research topics: Marine toxins, fecal metabolites, boar taint, bile acids, relation between meat consumption and DNA adduct formation etc. - CURRENT research topic: Metabolomic fingerprinting of the human gut phenotype in health and disease. - Substitute department head of Lab. Chemical Analysis - Managing role within the accreditation system of the lab.(BELAC (066-test), according to ISO17025) - Teaching experience (Analytical Chemistry, Chemical Dangers) at Ghent University (in 1st bachelor and 3rd master) Specialties: - UHPLC en LC-MS (ion trap, triple quadrupole, orbitrap, QqToF) experience, method development and validation - High resolution-accurate mass analysis - Detection of residues in various matrices (urine, feed, feces, sediment samples etc.) - Use of GC-MS - Application of static in vitro digestion model - Experience for cultivating human cell line cultures (HT-29, Caco-2) - ATNC (Apparent Total N-nitroscompound) analysis - UV and ELSD-based detection
My role as project leader is to ascertain human safety, regulatory and environmental safety/sustainability guidance to R&D and business partners for the Fabric Care products for Greater Europe. Additionally, I'm responsible for developing and implementing safety and regulatory solutions for the Fabric Care products. Some of my responsibilities are: * Defining and evaluating technical options for achieving business objectives * Preparing expert reviews, dossiers and risk assessments * Developing new work processes supporting safety and regulatory decision making
PhD granted by Ghent University at the department of Veterinary Public Health & Food Safety, Laboratory of Chemical Analysis on the project: 'Analytical approaches to unravel the semi-endogenous status of thiouracil'.
Was part of the team dedicated to the HLA-Antigen project, designed for the new technology platform “4-MATTM”. My main task within the team was to design, test and improve a new protocol for the purification of HLA Antibodies, and performing the necessary Quality Control routines. The research, mainly based on a trial and error improvement cycle, consisted out of a wide range of analytical techniques.